This brief video highlights the emerging treatment sotatercept, explaining how its novel mechanism of action significantly improves lung and heart function in PAH and discussing real world experience of telangiectasia in scleroderma patients treated with this agent.

Professor Edmund Lau
Senior Staff Specialist, Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney.

Professor Jean Elwing
Director of the Pulmonary Hypertension Program, University of Cincinnati, USA.

This video was created independently by the limbic. All content was developed by the presenters and views are those of the presenters alone.

Thank you to MSD for providing the unrestricted educational grant that made this project possible.